Brief

On November 21, 2024, the National Administration of Drugs, Food and Medical Technology (ANMAT) issued an update regarding ANMAT conducted a review of the National Vademecum of Medicines. This process aimed to ensure up-to-date information by removing outdated products, with 60 items being removed from the list, allowing only current products to be available for purchase. The review will be conducted quarterly, facilitating access to accurate information for laboratories, healthcare professionals, and the general public.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Administration of Drugs, Food and Medical Technology (ANMAT)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies